- change ups
Items Tagged with 'Perrigo'
DUBLIN — Allegan-based drugmaker Perrigo agreed Monday to buy Ireland's Elan for $8.6 billion — in a deal that should allow the rapidly growing company to incorporate in Ireland, reduce its tax bill and boost its royalty stream. Read More
Allegan-based Perrigo has begun what it claims is the first broad marketing and communications campaign to raise consumer awareness of, and confidence in, generic over-the-counter medications sold by major retailers under their own store brands. Read More
Perrigo Co. has begun shipments of guaifenesin tablets, the first generic equivalent to a Mucinex branded expectorant medicine. The tablets are going to Perrigo’s retail and wholesale customers, packaged and marketed under store and proprietary brands. Read More
Perrigo (Nasdaq: PRGO) has signed a merger agreement and completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals Ltd. for approximately £180 million or $283 million in cash. Read More
Perrigo (Nasdaq: PRGO) has received approval from the U.S. Food and Drug Administration for its New Drug Application for "testosterone gel 1%," which is comparable to AbbVie’s AndroGel 1% brand. Read More
Perrigo has signed a definitive agreement to acquire Velcera Inc. — an OTC pet health-products company in Yardley, Pa. — for $160 million in cash, with the acquisition expected to close this year. Read More